PRKACB variants in skeletal disease or adrenocortical hyperplasia: effects on protein kinase A
Stéphanie Espiard(Centre National de la Recherche Scientifique), Constantine A. Stratakis(Institute of Molecular Biology and Biotechnology), Davide Calebiro(University of Würzburg), Ludivine Drougat(National Institutes of Health), Michael A. Levine(Children's Hospital of Philadelphia), Sara Haydar(National Institutes of Health), Nikolaos Settas(National Institutes of Health), Kerstin Bathon(University of Würzburg), Edra London(National Institutes of Health), Dong Li(Children's Hospital of Philadelphia), Fábio R. Faucz(National Institutes of Health), Isaac Lévy(Tel Aviv University), Jérôme Bertherat(Centre National de la Recherche Scientifique)
Cited by 19
Related Papers
Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase
|Proceedings of the National Academy of Sciences|2004|745
SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1–SIX1–DNA complexes
|Proceedings of the National Academy of Sciences|2004|420
Consensus on diagnosis and management of Cushing's disease: a guideline update
|White Rose Research Online (University of Leeds, The University of Sheffield, University of York)|2021|351